ClinConnect ClinConnect Logo
Search / Trial NCT05907005

Instant Message-delivered Early Psychological Intervention in Stroke Family Caregivers

Launched by THE UNIVERSITY OF HONG KONG · Jun 7, 2023

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Cognitive Behavioural Therapy Ecological Momentary Intervention Early Psychological Intervention

ClinConnect Summary

This clinical trial is studying a new way to help family members who care for stroke patients. Many caregivers experience stress, anxiety, and depression, which can affect their health. The goal of the study is to provide early psychological support through a program delivered via instant messaging on mobile phones. This program, called internet-delivered cognitive-behavioral therapy (iCBT), aims to help caregivers change how they think about their situation and learn skills to cope better with the challenges they face.

To participate in this trial, you must be a primary family caregiver of a stroke patient who has moderate disability and has been in the hospital for at least 6 days but no more than 21 days. You should be at least 18 years old, able to communicate in Chinese (Cantonese or Putonghua), and comfortable using instant messaging on your phone. If you join, you can expect to receive support that can help reduce stress and improve your well-being as you care for your loved one. It's important to note that this trial is not for professional caregivers or those currently receiving other psychological treatments.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary family caregiver of first-ever stroke patient who has \<15 modified Barthel Index(mBI) scores (moderate disability);
  • Caregiver of a stroke patient who has a hospital inpatient stay of ≥6 days and ≤21days;
  • Aged ≥18;
  • Able to read and communicate in Chinese (Cantonese or Putonghua);
  • Able to use mobile phone instant messaging function; and
  • PHQ-9 (depressive symptom) score ranging from 5 to 19 (note. mild: 5-9, moderate: 10-14, moderately severe: 15-19 and severe: 20-27)
  • Exclusion Criteria:
  • Caregiver of stroke patient who is admitted to intensive care unit;
  • Professional medical personnel and/or professional carer;
  • Diagnosis of psychiatric disease before stroke event or currently taking psychotropic drug including antidepressants;
  • PHQ-9≥20 (we shall provide information on mental health services; if needed, we shall make the appropriate referrals); and
  • Currently participating in any type of psychological intervention.

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported